API Synthesis CROs in Switzerland

Leading CDMO providing custom development and manufacturing for the pharmaceutical and biotech industries. Lonza specializes in biologics, cell and gene therapy, and small molecule manufacturing.

Swiss CDMO providing integrated drug substance and drug product development services including API synthesis, process development, and highly potent compound manufacturing.

European CDMO network with 11 GMP facilities providing integrated API, drug product, and packaging services from pre-clinical through commercial scale including peptides, lipids, and injectables.

Swiss CDMO providing API synthesis, lipid nanoparticle manufacturing, and peptide production, known for large-scale mRNA lipid supply and complex pharmaceutical intermediates.

Swiss specialty CDMO focused on exclusive custom synthesis and manufacturing of hazardous chemical reactions, energetic compounds, and complex API intermediates for pharma and fine chemical clients.